DIAMONDBACK 360 CORONARY ORBITAL ATHERECTOMY SYSTEM DBEC-125 70058-13

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative,health report with the FDA on 2020-03-12 for DIAMONDBACK 360 CORONARY ORBITAL ATHERECTOMY SYSTEM DBEC-125 70058-13 manufactured by Cardiovascular Systems, Inc..

Event Text Entries

[183108212] The oad was received for analysis. Adhered, dried blood was embedded in the driveshaft. Examination of the area of the adhered material did not reveal any damage that would have contributed to the material accumulation. The exact root cause of the material accumulation is unknown. A guide wire passed through the driveshaft and oad handle, including the area of embedded material, with no resistance. The oad spun on all speeds and functioned as intended. At the conclusion of the device analysis, the reported events of vessel spasm, dissection, and no flow were unable to be conclusively confirmed through analysis. The device history record for this oad lot number has been reviewed. No issues or discrepancies were noted during this review that would have contributed to the reported event. The device met material, assembly, and quality control requirements. (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[183108213] During a procedure with a diamondback coronary orbital atherectomy device (oad), one treatment pass was completed on low speed for a 90%, severely calcified lesion in the mid-circumflex artery. The patient's circumflex and left anterior descending coronary artery spasmed, and there was no flow in the circumflex. A type f dissection occurred. The patient began to decompensate, and the circumflex was ballooned and stented. Imaging performed after angioplasty and stent deployment showed the vessel was open with a good treatment result. During angioplasty and stent deployment, the patient's heart rate and blood pressure could not be maintained; vasopressors were administered, and the patient was intubated. After stent deployment an intra-aortic balloon pump (iabp) was inserted. The patient was extubated on (b)(6) 2020, and the iabp was removed on (b)(6) 2020. It was reported the patient was fine as of (b)(6) 2020.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3004742232-2020-00070
MDR Report Key9823475
Report SourceCOMPANY REPRESENTATIVE,HEALTH
Date Received2020-03-12
Date of Report2020-03-12
Date of Event2020-02-12
Date Mfgr Received2020-02-12
Device Manufacturer Date2019-10-10
Date Added to Maude2020-03-12
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactSARAH HICKS
Manufacturer Street1225 OLD HIGHWAY 8 NW
Manufacturer CitySAINT PAUL, MN
Manufacturer CountryUS
Manufacturer G1CARDIOVASCULAR SYSTEMS, INC.
Manufacturer Street1225 OLD HIGHWAY 8 NW
Manufacturer CitySAINT PAUL, MN
Manufacturer CountryUS
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameDIAMONDBACK 360 CORONARY ORBITAL ATHERECTOMY SYSTEM
Generic NameCORONARY ATHERECTOMY DEVICE
Product CodeMCX
Date Received2020-03-12
Returned To Mfg2020-02-25
Model NumberDBEC-125
Catalog Number70058-13
Lot Number292925
OperatorHEALTH PROFESSIONAL
Device AvailabilityR
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerCARDIOVASCULAR SYSTEMS, INC.
Manufacturer Address1225 OLD HIGHWAY 8 NW SAINT PAUL, MN US


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2020-03-12

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.